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Background: The tumor suppressor protein p53 regu-
lates progression through the checkpoint between the
GI and S phases of the cell cycle in response to radiation-
or drug-induced DNA damage. We have examined po-
tential p53-mediated effects of metabolically labeling
cultured mammalian cells with [3 5S]methionine and
[3H]thymidine, methods that are commonly used to study
the biochemical properties, synthesis, processing and
degradation of proteins and the replication of DNA in
proliferating cells.
Results: Wild-type p53 protein concentrations rapidly
increased to high levels following metabolic radiolabeling
of cells, as determined by four distinct assays. The in-
creased concentration of wild-type p53 resulted in
apoptosis of normal human peripheral blood lymphocytes
and of murine T-cell acute lymphoblastic leukemia cells.
In leukemia cells containing no p53, or only mutant p53
alleles, p53 protein levels were not increased and the cells
did not undergo apoptosis in response to radioactive label-
ing. Radiolabeling of human diploid fibroblasts resulted in
a prolonged growth arrest that was maintained for nearly
three weeks.
Conclusions: The results of experiments employing
radiolabeling techniques to characterize various aspects of
cellular physiology may be seriously influenced by the
induction of aberrant cell-cycle arrest and/or apoptosis
mediated by wild-type p53. Furthermore, our observa-
tions suggest that stabilization of wild-type p53 in response
to irradiation may not act primarily to facilitate the repair
of DNA damage by inducing a transient Gl-phase arrest,
but rather to ensure genetic stability through sustained
cell-cycle arrest or apoptotic death of the damaged cells.
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Background
The tumor suppressor protein p53 functions as a media-
tor of genomic stability in mammalian cells by regulating
the transition through the G1/S-phase checkpoint dur-
ing the cell cycle. In normal cells, p53 protein levels are
intrinsically low as a result of the short half-life of the
wild-type p53 protein, as determined by radioactive
pulse-chase labeling experiments [1]. Stabilization and
an increase in the levels of wild-type p53 protein are
elicited in response to DNA-strand breakage, induced by
such diverse agents as ionizing radiation, ultraviolet
light, chemotherapeutic agents (such as cisplatin, mito-
mycin C or etoposide) [2-4], restriction enzymes and
the antimetabolites methotrexate and PALA (N-phos-
phoacetyl L-aspartate) [5,6]. Such increased levels of
wild-type p53 protein may induce either GI-phase cell-
cycle arrest [4,7,8] or apoptosis [9-12], depending on
the cell type. The detailed mechanism by which DNA
damage induces stabilization of wild-type p53, and the
mechanism by which elevated levels of wild-type p53
cause Gl-arrest or apoptosis, are unknown. However, it
has been observed that transactivation of several genes
known to contain p53-binding sites - gadd45 [7,13],
mdm2 [14] and p2 1 Cipl/WAF1/Sdi1 [15,16] - occurs after
treatment with DNA-damaging agents. Furthermore,
wild-type p53 decreases the expression of the apoptosis-
suppressing gene, bcl-2, while simultaneously stimulating
expression of bax, which encodes a dominant inhibitor
of the Bcl-2 protein [17].
We sought to determine the possible consequences of
metabolically labeling cultured mammalian cells, a proce-
dure that is commonly used to study a variety of biologi-
cal and biochemical characteristics. Incorporation of
either [3 5S]methionine or [3 H]thymidine led to an accu-
mulation of wild-type p53 protein, as demonstrated by
immunofluorescent staining, immunoprecipitation and
immunoblotting, as well as by quantitation of wild-type
p53 by enzyme-linked immunoabsorption assay (ELISA).
Stabilization, and hence the concentration, of wild-type
p53 increased in a dose-dependent manner with increas-
ing amounts of radioactive label used, as well as with the
length of the labeling period. Most importantly, cells in
which radioactive compounds were 'chased' for extended
periods of time with cold metabolites maintained highly
elevated levels of wild-type p53 protein for protracted
periods, leading to apoptosis or to long-term growth
arrest of all of the cells.
Results
Analysis of p53 protein by immunoprecipitation
To determine the effects of radioactive labeling on cul-
tured cells, we assessed the status of the p5 3 protein
in several murine acute T-cell lymphoblastic leukemia
(T-ALL) lines with p53 genes encoding only wild-type
or mutant protein. Representative examples are shown in
Figure 1. As shown in Figure la, [35S]methionine-labeled
cell lysates of T-ALL42 (wild-type p5 3) and T-ALL71
Correspondence to: Martin Haas.
© Current Biology 1995, Vol 5 No 4 423
424 Current Biology 1995, Vol 5 No 4
(both p53 alleles mutated, Lys-Gln at codon 129
(p53Ql2 9) [18]) were analyzed by SDS-polyacrylamide
gel electrophoresis (PAGE) after immunoprecipitation
with p53-specific antibodies. The anti-p53 antibodies,
G59 and PAb 421, which react with both wild-type and
mutant p53 proteins (lanes 2 and 3), readily detected p53
protein from both cell lines, whereas the murine anti-
body specific for wild-type p53, PAb 246, recognized
only wild-type p53 protein from T-ALL42 (lane 4) and
the mutant-specific antibody, PAb 240, recognized only
p53Q129 protein from T-ALL71 (lane 5).
To assess the steady-state levels of p53 protein in these
cell lines, unlabeled lysates were immunoprecipitated
with the panel of monoclonal antibodies shown in Figure
la, separated by SDS-PAGE and immunoblotted using
the polyclonal anti-p53 antibody CM1. As shown in
Figure lb, in the absence of radioactive labeling, wild-
type p53 protein produced by the T-ALL42 cell line was
not detectable, whereas the p53Q12 9 protein synthesized
by T-ALL71 was readily discernible.
The immunoblot assay was repeated following labeling
with [3 5S]methionine, to determine if the differences in
the detection of p53 by immunoprecipitation and im-
munoblotting depended on radioisotope-induced stabi-
lization of the protein. The results, shown in Figure c,
reveal that wild-type p53 and the mutant p53QI29 were
both readily detected by immunoblotting following
radioactive labeling of the cells.
Measurement of p53 accumulation in response to
[35S]methionine
To assess whether the increased detection of wild-type
p53 was attributable to its stabilization/accumulation in
response to radioactive labeling, T-ALL42 cells were la-
beled for 2 hours with various quantities of [3 5 S]methio-
nine, washed and replated in complete medium. Samples
taken at several time points were analyzed by ELISA for
the concentration of total intracellular p53. As shown in
Figure 2, the concentration of wild-type p53 protein in-
creased in a dose-dependent manner with increased
amounts of [3 5 S]methionine labeling. Measurable accu-
mulation of p53 commenced 1-2 hours after the addi-
tion of radioactive amino acids (Fig. 2a); a corresponding
decrease in cell viability, as determined by trypan blue
staining, was observed 4 hours after labeling, with a
sharp, dose-dependent decrease evident 8 hours after
labeling (a 56 % decrease in viability of cells labeled
with 25 ,uCi ml-1 to an 81 % decrease in cells labeled
with 100 ,uCi ml- 1; see Fig. 2b). DNA extracted from
cells at different times after labeling displayed the frag-
mentation characteristic of cells undergoing apoptosis
(data not shown). As shown in Figures 2c and 2d, the
concentration of wild-type p53 also increased with the
length of the labeling period. T-ALL42 cells were labeled
with 100 pxCi ml- [3 5 S]methionine for the indicated
periods of time, after which they were replated in com-
plete medium. There was a 2-fold increase in p53 by
4 hours after the commencement of labeling, and a 5- to
12-fold increase overall, depending upon the length of
the labeling time.
Cells synthesizing mutant p53Q129 did not show increased
stabilization of p53 protein, nor did they undergo apop-
tosis following the incorporation of radioactive methio-
nine (Fig. 2). Cells that were deficient in p53 protein, as
a result of a premature stop-codon mutation at codon
173 of the p53 gene, also did not undergo apoptosis in
response to labeling, whereas cells expressing one wild-
type p53 allele and one allele mutated at codon 246
(Arg--Gln) [18,19] responded in the same way as the
wild-type p53 cells did, by stabilizing p53 protein and
undergoing apoptosis (data not shown).
Immunofluorescence staining of p5 3 in unlabeled
T-ALL42 cells, compared with cells labeled for 2 hours
and then chased for 4 hours in cold medium, revealed
differential staining intensity as well as altered subcellular
localization. As shown in Figure 3a, the wild-type p53
of unlabeled T-ALL42 cells appeared as a diffuse halo
throughout the cytoplasm with distinct perinuclear con-
centration. If cells were examined 4 hours after a 2 hour
labeling period, the intensity of anti-p53 immunofluores-
cence was greatly increased, and all p53 protein was now
seen to concentrate primarily in the nucleus (Fig. 3b).
Measurement of p53 accumulation after labeling with
[3H]thymidine
Labeling of DNA by incorporation of radiolabeled thymi-
dine is a common method used for quantitating cellular
Fig. 1. Immunoprecipitation of p53 protein. Lysates of 5 x 106
cell equivalents per lane were immunoprecipitated with the anti-
bodies: PAb419 (Lane 1); G59 (lane 2); PAb421 (lane 3);
PAb 246 (lane 4); or PAb 240 (lane 5). (a) Autoradiograph of
SDS-PAGE of samples from cells labeled with 100 tCi ml-1
[3 5Smethionine for 2 h. (b) Immunoblot of unlabeled cell
lysates. (c) Immunoblot of cell lysates metabolically labeled with
100 iCi ml-1 [35S]methionine for 2 h .
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Fig. 2. Response of T-ALL42 cells to metabolic labeling. The concentration of p53 was measured by ELISA; the viability curves were
determined by trypan blue staining. (a) Wild-type p53 concentration and (b) viability of cells, as a function of dose. (c) Wild-type p53
concentration and (d) viability, as a function of length of labeling time. Each figure also shows the behavior of the T-ALL71 control cell
line synthesizing only mutant p53Q 12 9 protein. Data are representative of multiple experiments.
proliferation or as a prelude to measuring DNA damage.
For DNA-damage assays, DNA is labeled for one or two
cell generations, then incubated in the absence of label to
chase out any unincorporated radioactivity before treat-
ment with DNA-damaging agents [20]. We investigated
the ability of [3 H]thymidine to induce stabilization of
wild-type p53 in T-ALL42 cells. Cells were labeled with
either 25 luCi mi-l or 50 Ci mil- [3 H]thymidine for 4,
8 or 24 hours. Samples were then analyzed for p53 levels
and cell viability. As shown in Figures 4a and 4b, [3 H]thy-
midine labeling of DNA induced a marked increase of
wild-type p53 protein levels, similar to that induced
by [3 5 S]methionine labeling. The protein concentration
increased with extended time of exposure to the
[3 H]labeled thymidine, accompanied by concurrent loss
of viability of the cells.
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Fig. 4. Dose- and time-response of wild-type p53 accumulation
following radiolabeling with [3H]thymidine. (a) Wild-type p5 3
stabilization in response to metabolic labeling with 25 or
50 p.Ci ml-1 [3H]thymidine. After exposure for 4, 8 or 24 h, pro-
tein concentrations were measured by ELISA. (b) Viability as
.determined by trypan blue staining. Data are representative of
multiple experiments.
Fig. 3. Immunofluorescence staining of wild-type p53 protein in
T-ALL42 cells. (a) Unlabeled cells. (b) Cells labeled for 2 h with
100 IpCi ml-1 [3 5S]methionine and chased in complete medium
for 4 h. (600 x magnification.)
Effects of metabolic labeling with [35S]methionine on human
lymphocytes
Previous studies have shown that radiation-induced apop-
tosis of human lymphocytes [21,22] occurs with slower
kinetics than that of murine lymphocytes [23,24]. Addi-
tionally, comparison of the rate of apoptosis after X-
irradiation of unstimulated human lymphoid cells or
cells' activated with phytohemagglutinin (PHA) indicates
that there is a difference in survival time between resting
and activated human lymphocyte populations [21,22].
Furthermore, the apoptotic response of hematopoietic
cells is delayed and/or abrogated in the presence of high
concentrations of appropriate growth factors [25-29].
We assayed the effect of radioactive labeling on non-
activated, freshly isolated human peripheral blood lym-
phocytes and on activated lymphocytes grown in the
presence of 10 or 50 U m1-1 recombinant human inter-
leukin-2 (IL-2); IL-2 is required for the proliferation of
activated lymphocytes in culture. As shown in Figures 5a
and 5b, accumulation of wild-type p53 occurred in
freshly-isolated human peripheral blood lymphocytes as a
result of 2 hours radioactive labeling, with a correspon-
dent loss of viability of the cells. In activated human
peripheral blood lymphocytes, the increase in levels of
p53 and the loss of viability were moderated by increas-
ing the concentration of IL-2 to 50 U ml-1 (Figs 5c and
5d). The time after labeling of activated lymphocytes at
which viability was reduced to 50 % was 45 hours for
cells grown with 10 U ml- l IL-2, and 80 hours for cells
grown in the presence of 50 U ml-1 IL-2 . Hence, as has
been reported, the apoptotic response of human periph-
eral blood lymphocytes was delayed in the presence of
growth factor. Loss of viability of proliferating human
peripheral blood T cells occurred at a much slower rate
than that of the proliferating leukemic murine lymphoid
T cells shown in Figure 2.
Effects of radiolabeling on non-lymphoid cells
As initially reported by Harris and Lowenthal [24], mu-
rine fibroblastoid sarcoma cells do not lose viability in
response to ionizing radiation, as do many murine lym-
phoma cells. Similarly, in irradiated BALB/c mice, non-
lymphoid tissue retains its integrity whereas thymocytes
respond to irradiation by DNA fragmentation [23]. Ac-
cordingly, it was of interest to assay the effect of metabolic
labeling on non-lymphoid, diploid fibroblasts. Duplicate
dishes of subconfluent early passage human foreskin
fibroblasts were labeled for 2 hours with 100 pLCi ml-1
[3 5 S]methionine. At appropriate timepoints, one dish was
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Fig. 5. Accumulation of wild-type p53
and loss of viability of human peripheral
blood lymphocytes after labeling with
100 1iCi ml-1 [35S]methionine for 2 h.(a) Wild-type p53 concentration and (b)
viability, of unactivated lymphocytes;
(c) wild-type p53 concentration and
(d) viability, of activated lymphocytes
cultured in 10 or 50 U ml- 1 IL-2.
lysed for analysis of intracellular p53 by ELISA, while
duplicate dishes either had their fluid changed or were
trypsinized and replated in an attempt to stimulate cell
division. Cell cultures were maintained through. to the
end point of the experiment 7 days later. Unlabeled con-
trol plates were maintained by trypsinizing and replating
every 48 hours, at which point the cells had just reached
confluence. Isotope-induced stabilization of p53 was
rapid and long-lived in normal human fibroblasts (Fig.
6a), and was associated with an apparently permanent
growth arrest (Fig. 6b). Although the cells remained vi-
able, as determined by trypan blue exclusion, there were
absolutely no mitotic cells in the labeled cultures for the
7 day period of observation.
Fig. 6. Effects of radioactive labeling on
human diploid fibroblasts. (a) Elevation
of wild-type p53 levels as measured by
ELISA and (b) induced growth arrest, of
radiolabeled human foreskin fibroblasts
after 2 h of labeling with 100 /zCi ml-1
[35S]methionine.
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To examine whether the induced growth arrest of
human foreskin fibroblasts was reversible, the labeling
experiment was repeated and followed over a longer
period of time. Cell cultures were monitored and lysates
were collected at several time points over a 3 week pe-
riod. After pulse-labeling for 2 hours, the cultures were
washed, split 1:2 to ensure depletion of non-incor-
porated radioactivity and grown in complete medium
containing a 3 300-fold increased concentration of cold
methionine. (Medium was changed every 2-3 days and
unlabeled control cultures were routinely passaged to
keep them at a subconfluent density.) Within 2 hours of
labeling, there was only an average of two mitotic cells
per 100 x microscope field, and by 6 hours there was less
than one per field, whereas unlabeled control cultures
displayed more than 18 mitotic cells per field. The
labeled cultures consisted of enlarged, flattened senes-
cent-like cells which remained devoid of mitoses for
17 days. In an attempt to stimulate proliferation, cultures
were divided 1:2 after samples were taken for analysis of
the day 13 time point. On day 17 after labeling, some
mitotic cells were detected and there were many dead
cells. On day 18 after labeling, many mitotic cells were
observed, the cultures approached confluence and, when
split 1:2 on day 19, remained actively dividing until the
experiment was terminated on day 21.
Cell lysates were used to follow intracellular radioactivity
by scintillation counting and were immunoprecipitated
and analyzed by immunoblots to assess both p53 and p2 1
protein levels throughout the 3 week period. As shown
in Figure 7a, intracellular radiation levels remained
relatively high (2 000-12 000 cpm tpg -l protein) through
the first 2 weeks, and then dropped significantly to
< 250 cpm Ig - 1 protein by day 17. These levels correlate
with the proliferative arrest and subsequent release from
arrest described above. Figure 7b demonstrates the in-
creased levels of p5 3 through to day 17 (lanes 2-10), the
decreased level on day 19 (lane 11), and the increase
associated with confluent cultures (as seen in confluent
control, lane 13; and our unpublished observations) on
day 21 (lane 12). Figure 7c shows the increased p2 1 levels
apparent within 24 hours of radiolabeling; these re-
mained elevated through to day 10 (lanes 4-8) and then
decreased by day 13 (lane 9).
Is the response to radiolabeling exclusively a result of
intracellular irradiation?
As DNA-damage incurred by radiolabeling cells is
apparently caused by intracellular radiation, we sought to
determine whether the growth arrest or apoptosis in-
duced by [3 5 S]methionine was attributable solely to intra-
cellular exposure to radioactivity. Cells were labeled with
[35 S]methionine either in medium deficient in methio-
nine or in complete DMEM, which contains 3 300 times
more cold methionine than that contributed by the radi-
olabeled methionine. Diluting the radioactive methion-
ine to such an extent should lead to a similarly diluted
uptake of radioactivity. All of the T-ALL42 cells re-
sponded by undergoing apoptosis in both deficient and
Fig. 7. Intracellular radioactivity and p53/p21 status of labeled
human foreskin fibroblasts over a 3 week interval. (a) The
amount of radioactivity per g total cellular protein present in
cell lysates (as determined by Bio-Rad protein assay, using the
manufacturer's protocol) from each time point, determined by
scintillation counting. Protein (25 g) from lysates taken at each
time point was (b) immunoprecipitated with PAb 421 and
immunoblotted with CM1 antibodies or (c) immunoprecipitated
with a mixture of three anti-p21 monoclonal antibodies (see
Materials and methods) and immunoblotted with rabbit poly-
clonal anti-p21 antisera. Lanes: 1, unlabeled control; 2, 4 h; 3,
8 h; 4, 24 h; 5, 2 days; 6, 3 days; 7, 6 days; 8, 10 days; 9,
13 days; 10, 17 days; 11, 19 days; and 12, 21 days after labeling.
Lane 13 has the unlabeled control cells at confluence on day 21.
complete medium, with a significantly delayed response
when excess cold methionine was present. This suggests
that both intracellular and extracellular radiation con-
tribute to stabilization of wild-type p5 3 and some of the
resulting physiological consequences. The human fibrob-
lasts responded somewhat differently; when labeled in
methionine-deficient medium, they displayed a near-
total reduction of mitoses, from 20 mitoses per field
before labeling to 2 per field by 2 hours, and less than 1
per field by 6 and 24 hours after labeling. Fibroblasts
labeled in the presence of excess cold methionine showed
a transient reduction of mitoses from 20 per field before
labeling to 12 by 2 hours, 3 by 6 hours, but an increase
to 11 per field by 24 hours after labeling.
Discussion
The incidental effects of labeling metabolically active
substances in mammalian cells have been mentioned nu-
merous times, from early studies using tritiated water in
1950 and tritiated thymidine in 1959 (see [30]) to a re-
cent study in 1994 [31]. Our results confirm these find-
ings, and offer additional insight into the mechanism of
growth inhibition, perturbations in the cell cycle, mitotic
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inhibition and other phenomena that are directly related
to the exposure of cells to radioactive agents.
Initially, we found that wild-type p53 in murine T-ALL
cell lines was not detectable by immunoblotting unless
the cells were first metabolically labeled with [3 5 S]methio-
nine, demonstrating the low steady-state level of wild-
type p53 in lymphocytes and indicating the role of
radioactive labeling in stabilization of p53 protein. The
results and interpretation of published experiments that
have utilized radiolabeling to characterize various aspects
of cellular activity may have been unknowingly influ-
enced by the induction of cell-cycle arrest and/or apop-
tosis mediated by elevated levels of wild-type p53. For
example, our results suggest that data regarding the half-
life of many proteins, including that of wild-type p53,
may have produced overestimated values - a significant
increase in the stability of p53 protein occurs within
30 minutes of a 30 minute pulse-label, an increase that
would influence the accurate determination of protein
half-life measurements. The induced stability of wild-
type p53 is both dose- and time-dependent and occurs
with exposure to [3 H]thymidine as well as to [3 5 S]methio-
nine. The need for caution when interpreting data ob-
tained employing radiolabeling techniques should be
emphasized, as experimental results can be misleading if
the end points measured are affected by the incorporated
radioactivity.
We show that normal human peripheral blood lympho-
cytes and murine T-ALL cells expressing wild-type p53
respond to the radiolabeling-induced elevated levels of
p53 by undergoing apoptosis. Our results also demon-
strate that induction of apoptosis in activated human
lymphocytes is significantly attenuated by increasing the
level of IL-2 in the medium, as has been shown previ-
ously for several other hematopoietic growth factors
[25-29]. Hence, protection of bone marrow cells from
the effects of chemotherapeutic agents or radiation by the
administration of growth factors or interleukins may be
mediated by a decrease in levels of apoptosis, rather than
by the induction of progenitor cell proliferation. The
extreme sensitivity of lymphocytes to radiation and to
the subsequent 5- to 20-fold increased p53 levels is con-
ceivably a reflection of the importance to the organism of
maintaining complete integrity of immune function; cells
choose to delete genetically compromized cells through
apoptosis rather than allowing them to continue prolifer-
ating and interfering with proper functioning of the
immune system.
In contrast to the results with human and murine
lymphocytes, we demonstrated that diploid human fore-
skin fibroblasts respond to stabilization of wild-type p5 3
protein by the rapid induction of a sustained growth
arrest. G-phase cell-cycle arrest of human fibroblasts
mediated by p53 has been suggested to occur through
the transcriptional activation of p21 [16]. Our data show
that, although the levels of p53 and p21 proteins increase
consecutively after radioisotope incorporation, the levels
of p21 protein decline 3-6 days before the cells are
released from proliferative arrest (Fig. 7). This decline oc-
curs despite p53 protein levels remaining elevated, sug-
gesting that the cell maintains p53-mediated arrest
through p21-independent pathways as well. Interest-
ingly, we have also observed that confluent cultures of
human diploid fibroblasts have increased concentrations
of wild-type p53 (Fig. 7, lanes 12 and 13) without con-
current increased expression of p2 1 . Hence, although
up-regulation of wild-type p53 and p21 is associated with
DNA damage and the senescent state in human fibro-
blasts [32], p2 1 seems not to be involved in the cessation
of proliferation that is due to contact inhibition.
Finally, our finding that lymphoid cells and fibroblasts
responded similarly to radioactive labeling in the pres-
ence of excess cold methionine (which presumably rep-
resents mostly extracellular irradiation) as they did to
labeling in methionine-free medium, was surprising.
Several mechanisms may account for these results. Firstly,
a minute amount of induced DNA damage may be suffi-
cient to elicit an apoptotic response by lymphocytes,
whereas in fibroblasts this minimal damage may allow for
earlier resumption of proliferation compared with cells
labeled in methionine-deficient medium. Alternatively,
the effects of extracellular radiation may be mediated by
a wholly different mechanism, such as oxidation at the
cell membrane. Several studies have suggested pathways
through which reactive oxygen intermediates could
impinge upon a p53 response without necessitating direct
DNA damage. It has been shown [33] that the extracel-
lular signal-regulated MAP kinases are stimulated by the
production of reactive oxygen intermediates resulting
from treatment with X-rays, phorbol esters and H2 02 .
Milne et al. [34] report that p53 is phosphorylated by
MAP kinase, thereby suggesting a possible means of sta-
bilization of p53 by extracellular recognition of oxidative
stress. Additionally, a signaling pathway for response to
ultraviolet B light independent of chromosomal DNA
damage has been found to lead to activation of the nu-
clear factor NF-KB [35], which has also been implicated
in the activation of p53 [36].
Conclusion
Metabolic labeling with either [35S]methionine or
[3 H]thymidine, methods that are widely used to charac-
terize various aspects of the biological and biochemical
functions of mammalian cells, causes highly significant
stabilization of wild-type p53, leading to apoptosis or
long-term cell-cycle arrest. The induced stability of p53
is both dose- and time-dependent, and the ensuing con-
sequences are cell-type specific. Normal human periph-
eral blood lymphocytes and murine T-ALL cells ex-
pressing wild-type p53 undergo apoptosis, an effect that
is moderated in activated human lymphocytes by the
addition of exogenous growth factor. Human diploid
fibroblasts respond by a rapid induction of long-term
growth arrest, with cultures remaining devoid of mitotic
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cells for up to 18 days. The repercussions of these find-
ings for experimental procedures are important and may
require the redesign of some protocols in studies invol-
ving measurements of protein turnover and cell-cycle
kinetics This may include the use of more controls, lower
specific-activity radioisotopes, shorter exposure or, where
possible, non-radioactive methods.
Materials and methods
Cells and cell culture
Murine radiation-induced T-ALL lines were established as
described previously [37,38]. Human peripheral blood lympho-
cytes were isolated from whole blood using centrifugation over
Ficol-Paque (Pharmacia) according to the manufacturer's proto-
col. Lymphocytes were activated with 1 % phytohemaglutinin
(PHA; CalBiochem) and grown in the presence of the indicated
concentration of human recombinant interleukin-2 (IL-2;
Cetus). Human foreskin fibroblasts were grown for 2-3 passages
from normal tissue kindly donated by Sharp Memorial Hospital,
San Diego. Patient's consent (mother's written consent) was
obtained in each case and use of the tissue was authorized by
the UCSD and the Sharp Human Subjects Committees.
Foreskin fibroblasts were stored in liquid nitrogen until used.
All cells were maintained in Dulbecco-Vogt modified Eagle's
medium (DMEM) with the addition of non-essential amino
acids (100-fold for MEM; Irvine Scientific), 4 mM L-glutamine
(Irvine Scientific), 100 pM thioglycerol, 150 VpM asparagine
and 10 % fetal calf serum (HyClone).
Metabolic labeling, immunoprecipitation and
immunoblotting
For metabolic labeling with [35 S]-methionine/cysteine (trans-
label, ICN), cells were incubated for I h in DME met-/cys-
medium (Sigma) with 10 % dialyzed fetal calf serum. Unless
otherwise stated, 100 ,.Ci ml- l was added for a period of 2 h.
For immunoprecipitations, 5 x 106 cells were used for each
precipitation. Cells were washed twice in PBS, lysed for 15 min
on ice in 250 mM NaCl, 0.1 % NP40, 50 mM Hepes (pH7),
1 mM EDTA, 500 p.M PMSF and 1 % aprotinin prior to cen-
trifugation at 100 000 x g for 30 min. The supernatant was
incubated with the appropriate antibody overnight at 4 °C.
Immune complexes were collected on immobilized recombi-
nant protein A (Repligen), washed three times with lysis buffer,
once with PBS, boiled for 2 min in sample buffer and elec-
trophoresed on a 10 % SDS-polyacrylamide gel (12.5 % for
p21). Samples were either visualized by autoradiography or
transferred to nitrocellulose paper, blocked with 5 % non-fat
dry milk, and incubated with the appropriate rabbit polyclonal
antibody overnight at 4 °C. The peroxidase-conjugated donkey
anti-rabbit IgG (Amersham) was incubated with the blot for 1 h
at room temperature and detected (after exposure to film for
1-10 min) by enhanced chemiluminescence (Amersham). For
labeling with [3H]thymidine, cells were incubated in medium
containing 25 .LCi ml-1 or 50 l.Ci ml- I [3H]thymidine (specific
activity 60-90 Ci mmole-1; ICN) for the indicated periods.
ELISA
Cell extracts of 1 x 107 cells in 100 1 l lysis buffer (described
above) were applied to ELISA plates coated with the capture
antibody PAb 421 (30 jig ml- l) and incubated at 4 °C over-
night. After three washes, CM1 antibody was added for 2 h
at room temperature, removed and anti-rabbit IgG HRP-
conjugated antibody was incubated on the plate for 1 h.
Visualization was by the addition of the substrate ABTS
(Sigma) and the optical density of the plate was read at 405 nm.
Antibodies
Monoclonal antibodies G59 (Pharmingen) and PAb 421 [39],
and polyclonal antibody CM1 [40] (BioGenex) recognize both
human and mouse p53. Monoclonal antibody PAb 246 [41]
recognizes only murine wild-type p53 and PAb 240 [42]
detects most mutant p5 3 proteins. PAb 419, used as a non-spe-
cific control, recognizes SV40 large T antigen [39]. Mono-
clonal antibodies 18A10, 2G12 and 6B6 (Pharmingen) and the
rabbit polyclonal antibody (Cat#15431E; Pharmingen) were
used in p21 analysis.
Immunofluorescent cell staining
Slides were prepared by cytocentrifuging (200 r.p.m., 2 min)
105 cells resuspended in 100 pLL Hanks balanced salt solution
(HBSS). Slides were air-dried and fixed in 2 % paraformalde-
hyde/0.2 % gluteraldehyde solution for 10 min at room
temperature. Cells were then permeablized in 0.2 % Triton X-
100 for 5 min at room temperature, blocked for 1 h in
PBS + 10 % FBS and stained with PAb 421 (1:30) at 4 °C
overnight. Slides were washed three times and labeled with
FITC-conjugated anti-mouse IgG (1:350; Cappel) for 1 h at
room temperature, washed three times, air-dried and mounted.
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